Pathway enrichment analysis revealed that low expression of NEDD4L and high expression of RAC2 shared many similar tumor-associated pathways, including immune regulation, the proteasome pathway, cell adhesion, cell cycle, the Toll-like receptor signaling pathway, the JAK-STAT signaling pathway, and leukocyte transendothelial migration. Here, NEDD4L is linked to neoplasm.